In contrast to the results of the current study, previous studies showed that NF-κB could negatively regulate mTOR at the transcriptional level through receptor interacting protein 1 (RIP1), which played a key role in NF-κB activation in a glioblastoma cell line [40, 41]. Here, RIPK1 is linked to glioblastoma.